Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Insulet Q3 2026 Results: Net Income $141M, Up 61.1% YoY

Insulet Corp reported total revenue of $842.0 million for the quarter ended September 30, 2026, a significant increase from $706.3 million in the prior year period. Net income rose to $141.1 million, or $2.03 per diluted share, driven by strong gross profit margins and the absence of related-party revenue dependencies seen in 2025.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue842.0706.3
Gross profit632.1510.1
Profit before tax177.2122.8
Net income141.187.6
EPS (diluted, $ a share)$2.03$1.24

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year+61.1%
Revenue, year on year+19.2%
Gross margin75.1%
Operating margin22.5%
Source

10-Q filed with the SEC, NASDAQ: PODD. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Insulet Corp: key numbers

Share price
$145.29Close, Nov 16
Market cap
$10.1B
Shares outstanding
69.37MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Insulet Corp

All →
7:02 AM ET 8-K
Financial Results

Insulet Financial Results

Insulet reported Q3 2026 revenue of $842 million, a 19.2% increase year-over-year, driven by strong Omnipod sales in both U.S. and international markets. Alongside the earnings, the company announced a new $1 billion stock repurchase program authorized through 2028, with $400 million planned for the fourth quarter of 2026.

5:03 PM ET 8-K
Loan & Debt

Insulet $725M Debt Financing with Morgan Stanley Senior Funding, Inc.

Insulet Corporation entered into a ninth amendment to its credit agreement to refinance $475 million in existing term loans with new term loans at a 0.25% lower interest rate margin. Additionally, the company increased its revolving credit facility commitments by $250 million to a total of $750 million and reduced the applicable interest rate margins for revolving loans.

Value
$725M
Counterparty
Morgan Stanley Senior Funding, Inc.
4:03 PM ET 8-K
Executive Compensation

Insulet Executive Compensation

Insulet Corporation adopted a new Nonqualified Deferred Compensation Plan effective January 1, 2027, for a select group of management and highly compensated employees, including named executive officers. The plan allows participants to voluntarily defer up to 60% of their cash compensation and permits the company to make discretionary matching or nonelective contributions subject to a two-year vesting schedule.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.